SERVING OVERLOOKED PATIENTS
Live / Registered — Registered (as of 09 Dec 2025)
What this means for you
Registered since 09 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98212907
- Registration number
- 8061555
- Mark type
- Stylized text
- Filed
- 06 Oct 2023
- Published for opposition
- 17 Sept 2024
- Registered
- 09 Dec 2025
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of reformulated pharmaceuticals in the field of cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines; custom reformulation of pharmaceuticals for easier patient delivery
- Class 044 — Medical, beauty and agricultural services: Providing information to patients in the fields of administering medication and how medicines are designed to bring patients new formulations and dosage innovations to help them benefit from existing medicines
Owner
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
Prosecution history
- 09 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 18 Nov 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Nov 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Oct 2025 — ASSIGNED TO LIE
- 28 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Oct 2025 — NON-FINAL ACTION E-MAILED
- 06 Oct 2025 — SU - NON-FINAL ACTION - WRITTEN
- 13 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Mar 2025 — USE AMENDMENT FILED
- 12 Sept 2025 — SOU EXTENSION 1 GRANTED